February 22, 2017
Swiss-based Debiopharm International SA said on February 21 that it has filed an appeal with Japan’s Supreme Court against a lower-court ruling that found an Elplat (oxaliplatin) generic marketed by Nippon Kayaku does not infringe its patent. Debiopharm has demanded...read more